Market Place
Sourcing Support
Merck Inks $349M Biobucks Deal to Apply AI to Tricky Targets
24 Sep 2025 //
FIERCE BIOTECH
Kennedy Targets Childhood Vaccines, History of Merck`s ProQuad
23 Sep 2025 //
BIOSPACE
LifeSpan Portfolio Co. Remedium Inks Landmark Deal with Eli Lilly
23 Sep 2025 //
PR NEWSWIRE
Study: One-Third of Trial Data May Be Unnecessary
19 Sep 2025 //
FIERCE BIOTECH
Merck Gets Positive CHMP Opinion for Enflonsia in RSV Prevention
19 Sep 2025 //
PHARMAWEB
FDA Approves Merck`s Injectable Version of Blockbuster Keytruda
19 Sep 2025 //
REUTERS
Merck, St. Louis Cardinals Pitch Heart Disease Awareness Push
17 Sep 2025 //
FIERCE PHARMA
UK Lawmakers Question Pharma Execs Over R&D Pullback
16 Sep 2025 //
FIERCE BIOTECH
FDA Grants Breakthrough Tag to Raludotatug Deruxtecan in CDH6
15 Sep 2025 //
BUSINESSWIRE
Merck touts Capvaxive`s potential to provide protection for kids
11 Sep 2025 //
FIERCE PHARMA
Merck Scraps £1 B Project, Along with All R&d Operations in UK
10 Sep 2025 //
FIERCE BIOTECH
Daiichi, Merck Prepare for Swift Approval Filing
07 Sep 2025 //
FIERCE BIOTECH
Merck Names David Weinreich Global R&D Head and Healthcare CMO
03 Sep 2025 //
INDPHARMAPOST
Merck`s Cholesterol Drug Gets a Boost with Another LateTrial
03 Sep 2025 //
PRESS RELEASE
Merck, Bayer`s Verquvo Records Puzzling Trial Failure
02 Sep 2025 //
FIERCE PHARMA
Merck to Present at 2025 Wells Fargo Healthcare Conference
28 Aug 2025 //
PHARMAWEB
HERTHENA-Breast04 Ph3 Starts for Patritumab Deruxtecan in Cancer
27 Aug 2025 //
BUSINESSWIRE
Merck Showcases Cardiovascular Advancements at ESC Congress 2025
25 Aug 2025 //
PHARMAWEB
BioNxt Fast-Tracks Patent for Ms Drug, Secure Autoimmune Pipeline
20 Aug 2025 //
PHARMAWEB
Enforcement Report - Week of August 20, 2025
20 Aug 2025 //
FDA
Merck, Mantro Launch Edi Membre for Alternative Protein Industry
18 Aug 2025 //
INDPHARMAPOST
Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation
18 Aug 2025 //
CONTRACTPHARMA
Merck Cuts 58 NJ Jobs in Cost-Reduction Plan
13 Aug 2025 //
FIERCE PHARMA
Padcev-Keytruda Combo Delivers Bladder Cancer `breakthrough`
13 Aug 2025 //
PRESS RELEASE
Merck to Lay Off 58 Employees at Rahway HQ
12 Aug 2025 //
BIOSPACE
Merck Had No Other Competition in Its $10 B Buyout of Verona
07 Aug 2025 //
FIERCE PHARMA
Janux Hits Clinical Milestone in Merck TRACTr Collaboration
05 Aug 2025 //
BUSINESSWIRE
Merck to Cut 8% of Workforce, Laying Off 6,000
31 Jul 2025 //
FIERCE PHARMA
Merck Axes Main Asset from $1.9 B Pandion Buyout
30 Jul 2025 //
FIERCE BIOTECH
Merck Cuts $3 B to Support Aggressive Launch Schedule
30 Jul 2025 //
BIOSPACE
Merck & Co Announces Q2 2025 Financial Results
29 Jul 2025 //
BUSINESSWIRE
Merck`s Biologics Keytruda Receives Suppl Approval in US
24 Jul 2025 //
FDA
Merck Announces Fourth-Quarter 2025 Dividend
22 Jul 2025 //
BUSINESSWIRE
Merck Adopts Veeva Vault CRM
21 Jul 2025 //
CONTRACTPHARMA
EU Grants Conditional Approval of Ezmekly for Patient with NF1-PN
18 Jul 2025 //
GLOBENEWSWIRE
Merck Introduces AAW Workstation for Lab Automation Advancement
15 Jul 2025 //
INDPHARMAPOST
Merck to Start Phase 3 Trials for Monthly HIV Prevention Pill
14 Jul 2025 //
BUSINESSWIRE
FDA Gives Nod to Merck`s Bravecto Quantum
11 Jul 2025 //
INDPHARMAPOST
Merck`s Doravirine/Islatravir NDA Accepted by FDA
10 Jul 2025 //
BUSINESSWIRE
Merck Animal Health`s Bravecto® Quantum Gets FDA Approval
10 Jul 2025 //
BUSINESSWIRE
China`s 9-valent HPV vaccine priced at 60% discount to Merck jab
10 Jul 2025 //
FIERCE PHARMA
Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
10 Jul 2025 //
PRESS RELEASE
Merck to Unveil Hiv Prevention, Treatment Data at IAS 2025
09 Jul 2025 //
INDPHARMAPOST
Certara Expands Clinical Tech Collaboration with Merck
08 Jul 2025 //
GLOBENEWSWIRE
FDA Grants Priority Review for Winrevair Label Update
02 Jul 2025 //
BUSINESSWIRE
Merck`s Q2 2025 Sales and Earnings Call Set for July 29
01 Jul 2025 //
BUSINESSWIRE
ACIP Backs Merck’s ENFLONSIA for RSV in Infants
26 Jun 2025 //
BUSINESSWIRE
US CDC vaccine panel postpones vote on RSV therapies
25 Jun 2025 //
REUTERS
Merck Investor Event: Advancing HIV Treatment Research
24 Jun 2025 //
BUSINESSWIRE
Merck`s WINREVAIR™ Met Primary Endpoint in PAH Study
23 Jun 2025 //
BUSINESSWIRE
IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Begins
18 Jun 2025 //
BUSINESSWIRE
Keytruda Nod Highlights CEL-SCI Opportunity in PD-L1– Cancers
18 Jun 2025 //
BUSINESSWIRE
Keytruda`s Novel Head and Neck Cancer Nod Comes with A Limit
14 Jun 2025 //
BUSINESSWIRE
FDA Approves Keytruda for Local Advanced Head & Neck Cancer
13 Jun 2025 //
BUSINESSWIRE
Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate
13 Jun 2025 //
BUSINESSWIRE
Merck Animal Health gets EU CVMP nod for Numelvi
12 Jun 2025 //
BUSINESSWIRE
FDA limits Merck`s Keytruda, BMS` Opdivo in Stomach Cancer
10 Jun 2025 //
FIERCE PHARMA
US FDA Approves Merck`s RSV Antibody for Infants
10 Jun 2025 //
REUTERS
Merck`s Cholesterol Drug Meets Main Goal in Two Studies
09 Jun 2025 //
REUTERS
Merck to Join 46th Annual Goldman Sachs Healthcare Conference
04 Jun 2025 //
BUSINESSWIRE
